Chuck Royce (Royce & Associates) other Arcutis Biotherapeutics, Inc.
Chuck Royce (Royce & Associates) other $4.2M of disclosed value in Arcutis Biotherapeutics, Inc..
Signal
Investor Move
Action
Other
Capital
$4.2M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.